Paul Y. Song, MD is Chief Operating Officer and Chief Medical Officer of NKMax (formerly known as ATGen Global) where oversees all US Operations and the worldwide translational and clinical research programs. He is also a founding partner and chief medical officer of Hawkeye Bio and serves as a medical advisor to Supportive Therapeutics. Dr. Song previously served as the Chief Medical Officer of Berg Health from 2009 to 2012.
He was most recently on the faculty of the Samuel Oschin Cancer Center at Cedars Sinai Medical Center and currently sees Medicaid and uninsured patients at Dignity California Hospital.
Dr. Song served as the very first visiting fellow on healthcare policy in the California Department of Insurance in 2013. He is President of Physicians for a National Health Program California and is currently a board member of Healthcare Now, Physicians for a National Health Program, and Progressive Democrats of America.
Dr. Song graduated with honors from the University of Chicago and received his M.D. degree from George Washington University. He completed his residency in radiation oncology at the University of Chicago where he served as Chief Resident and did a brachytherapy fellowship at the Institute Gustave Roussy in Villejuif, France. He was also awarded an ASTRO research fellowship in 1995 for his research in radiation inducible gene therapy.